Clinical Trial Update: Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784) [Phase 3]

View source ↗

Summary

Phase 3 long-term efficacy and safety trial evaluating asenapine with olanzapine as a positive control in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Asenapine (asenapine)
• olanzapine (olanzapine)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED